首页 > 市场调查报告书 > 医疗设备

导管泌尿科

市场调查报告书

商品编码

1643904

全球输尿管支架市场 - 2025-2033

Global Ureteral Stents Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 209 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球输尿管支架市场达到5.2145亿美元，预计2033年将达到8.5024亿美元，2025-2033年预测期间复合年增长率为5.8%。

输尿管支架是放置在输尿管中的一根薄的柔性管，它将尿液从肾臟转移到膀胱。其主要功能是预防或治疗干扰尿流的阻塞，这种阻塞可能是由肾结石、肿瘤或狭窄等许多医疗问题引起的。输尿管支架的设计目的是保持输尿管足够宽，使尿液能够正确地从肾臟流到膀胱。他们经常在堵塞的情况下使用。

对输尿管支架的需求不断增长是预测期内推动市场的驱动因素。这种需求的增加可能与各种相互关联的原因有关，包括泌尿系统问题的盛行率上升、老年人口的增加以及支架技术的进步。所有这些因素共同增加了对输尿管支架的需求并推动了市场的发展。

市场动态：

驱动程式和限制

输尿管支架的需求不断增加

对输尿管支架的需求不断增长预计将成为全球输尿管支架市场成长的重要因素。由于肾臟相关疾病数量的增加、投资的增加和技术的进步，全球输尿管支架市场可望大幅扩张。肾臟相关疾病发生率的上升对输尿管支架需求的增加产生了重大影响。

例如，根据美国国立卫生研究院的数据，慢性肾臟病是一种进行性疾病，影响着全球 10% 以上的人口，即全球 8 亿多人。此外，根据美国国家肾臟基金会的数据，全球有超过 200 万人正在接受透析或肾臟移植治疗以维持生命，然而，这项估计可能只代表实际需要治疗才能生存的人的 10%。随着这些问题变得越来越普遍，对输尿管支架置入术等有效治疗的需求也随之增加。

近年来，许多资金和投资被用于输尿管支架的研究、开发和製造。例如，2024 年 11 月，泰米尔纳德邦政府与美国路博润签署了一份谅解备忘录 (MoU)。此次合作耗资约 20 亿印度卢比，为输尿管支架、神经血管和心血管治疗、静脉导管、血液透析管和中心静脉导管等关键应用生产高品质医用管材。投资的增加，增加了输尿管支架的产量，以满足输尿管支架不断增长的需求，并带动了市场。

支架取出后併发症的高风险

支架移除后併发症的高风险等因素预计将阻碍全球输尿管支架市场。感染、血尿和急性疼痛等併发症可能会对患者的生活品质产生重大影响，从而增加患者使用这些设备的意愿。刺激性排尿症状，例如尿急、频尿和不适，是支架移除后最常见的后果之一。此外，切除后可能会出现更严重的併发症，例如泌尿道感染和长时间出血，需要额外的手术治疗。对这些潜在后果的恐惧可能会导致患者变得焦虑，泌尿科医生可能不愿意建议支架置入术作为第一线治疗选择。

A ureteral stent is a thin, flexible tube placed in the ureter, which transfers urine from the kidneys to the bladder. Its major function is to prevent or treat obstructions that interfere with urine flow, which can be caused by a number of medical problems such as kidney stones, tumors, or strictures. Ureteral stents are designed to keep the ureter wide enough for urine to pass properly from the kidney to the bladder. They are frequently employed in situations where there is a blockage.

The increasing demand for ureteral stents is the driving factor that drives the market over the forecast period. This increase in demand can be linked to various interrelated causes, including the rising prevalence of urological problems, the increasing geriatric population, and advances in stent technology. All these factors together increase the demand for ureteral stents and it drives the market.

Market Dynamics: Drivers & Restraints

Increasing demand for ureteral stents

The increasing demand for ureteral stents is expected to be a significant factor in the growth of the global ureteral stents market. The global ureteral stents market is poised for significant expansion, owing to the rising number of kidney-related disorders, increasing investments, and technological advancements. The rising incidence of kidney-related conditions has a substantial impact on the increasing demand for ureteral stents.

For instance, according to the National Institute of Health, chronic kidney disease is a progressive disorder that affects more than 10% of the world's population, or over 800 million people across the globe. Moreover, according to the National Kidney Foundation, over 2 million people worldwide are receiving treatment with dialysis or a kidney transplant to stay alive, however, this estimate may only represent 10% of people who actually need treatment for their survival. As these problems become increasingly common, the demand for effective treatments, such as ureteral stenting, has increased.

In recent times, many funds and investments have been made for research, development, and manufacture of ureteral stents. For instance, in November 2024, The Tamil Nadu government and Lubrizol, based in the United States, signed a Memorandum of Understanding (MoU). The partnership, which cost approximately INR 200 crore, generated high-quality medical tubing for key applications such as ureteral stents, neurovascular and cardiovascular treatments, intravenous catheters, hemodialysis tubes, and central venous catheters. The increased investments, increase the production volume of the ureteral stents to meet the increasing demand for ureteral stents and it drives the market.

High risk of complications post-stent removal

Factors such as the high risk of complications post-stent removal are expected to hamper the global ureteral stents market. Complications such as infection, hematuria, and acute pain can have a major impact on patient quality of life, increasing reluctance to use these devices. Irritative voiding symptoms, such as increased urine urgency, frequency, and discomfort, are one of the most prevalent consequences of stent removal. Furthermore, more serious complications such as urinary tract infections and prolonged bleeding may occur following removal, necessitating additional surgical treatments. Fear of these potential consequences can cause patients to become anxious, and urologists might become reluctant to suggest stenting as a first-line treatment option.

Segment Analysis

The Global Ureteral Stents Market is segmented based on Product Type, Material, Application, End-User, And Region.

Double pigtail stents segment is expected to dominate the global ureteral stents market share

The double pigtail stents segment is anticipated to dominate the global ureteral stents market owing to their unique design, featuring coiled ends and technological advancements.

These stents are distinguished by their unique shape, which includes coiled ends that assist anchor the stent within the urinary tract, successfully avoiding migration and ensuring solid placement. This design not only reduces the risk of issues associated with stent displacement but also allows for better compliance with the anatomical structure of the urinary system, thereby improving patient comfort during use. This unique shape of the stent makes it user-friendly for the patients and increases the demand for the double pigtail stents making this the most dominating segment in the global ureteral stents market.

Recent technological advancements and launches have boosted the acceptance of double pigtail stents. For instance, in December 2024, The RELIEF ureteral stent was approved as the first and only stent for the prevention of vesicoureteral reflux, which is a major source of patient discomfort. Technological improvements and recent launches such as RELIEF ureteral stents have aided the development of minimally invasive insertion techniques for double pigtail stents. These procedures not only improve the simplicity of implantation but also minimize recuperation time for patients, increasing their acceptance in medical facilities and making them the most dominating segment in the global ureteral stents market.

Geographical Analysis

North America is expected to hold a significant position in the global ureteral stents market share

North America is expected to hold a significant portion of the global ureteral stents market. North America will likely account for a significant share of the global ureteral stents market, owing to its rising number of kidney-related disorders, increasing healthcare investments, advanced healthcare infrastructure, and technological advancements. One of the primary drivers of this demand in North America is the single number of kidney-related disorders.

For instance, according to the American Kidney Fund, more than 35.5 million Americans suffer from kidney disease. An estimated 808,000 Americans suffer from kidney failure. More than 557,000 Americans are on dialysis. Kidney disease is spreading at an alarming rate. It currently affects more than one in every seven (14% of American adults). In 2021, more than 135,000 Americans were diagnosed with kidney failure. Nine out of 10 individuals with renal disease were unaware of their status, and one-third of those with severely impaired kidney function were also unaware. Due to the increasing number of kidney-related disorders, the need for ureteral stents is increasing which helps ensure proper flow of urine through the ureter, this increases the demand for ureteral stents and drives the market in North America.

Asia Pacific is growing at the fastest pace in the global ureteral stents market

The Asia Pacific region is emerging as the fastest-growing market for ureteral stents, owing to a rising prevalence of urological disorders, increasing healthcare investments, and technological advancements. The increasing number of kidney-related disorders and renal replacement therapies are the primary reasons for the upsurge and growth of the market in the Asia Pacific region. For instance, the estimated prevalence of CKD is 800 per million people (pmp), while the incidence of end-stage renal disease (ESRD) is 150-200 pmp. Diabetic nephropathy is the leading cause of chronic kidney disease in population-based research. In India, nearly 18,000-20,000 patients (10% of new ESRD cases) receive renal replacement therapy, with over 172 transplant centers, the majority of which are privately run and located in South India. Each year, nearly 3,500 transplants are performed, with approximately 700 cadaver donors. Due to the increasing number of kidney-related disorders, the improper flow of urine is increasing which increases the demand for the ureteral stents market in the Asia Pacific region.

Competitive Landscape

The major global players in the global ureteral stents market include Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, Coloplast Ltd., BD, Medline Industries, Inc., Allium Medical Solutions Ltd, Pnn Medical A/S, Teleflex Incorporated, Olympus Corporation among others.

Emerging Players

Mitra Industries, InVivo Bionics, and ZygoFix among others

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global ureteral stents market report delivers a detailed analysis with 70+ key tables, more than 60 visually impactful figures, and 250 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Material
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Increasing Demand for Ureteral Stents
4.2. Restraints
- 4.2.1. High Risk of Complications Post-stent Removal
- 4.2.2. Opportunity
- 4.2.3. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Multiloop*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Open-end stents
6.4. Closed-end stents
6.5. Double pigtail stents

7. By Material

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 7.1.2. Market Attractiveness Index, By Material
7.2. Metal stents*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Silicone stents
7.4. Hybrid stents
7.5. Polyurethane stents
7.6. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Kidney stones*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Kidney transplantation
8.4. Tumors
8.5. Urinary incontinence
8.6. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. The U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Boston Scientific Corporation*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. B. Braun Holding GmbH & Co. KG
12.3. Cook Group Incorporated
12.4. Coloplast Ltd.
12.5. BD
12.6. Medline Industries, Inc.
12.7. Allium Medical Solutions Ltd
12.8. Pnn Medical A/S
12.9. Teleflex Incorporated
12.10. Olympus Corporation

LIST NOT EXHAUSTIVE